Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash from Operations (2016 - 2023)

Historic Cash from Operations for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to -$3.2 million.

  • MediWound's Cash from Operations rose 1376.46% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 95.88%. This contributed to the annual value of -$13.6 million for FY2024, which is 3018.63% down from last year.
  • Per MediWound's latest filing, its Cash from Operations stood at -$3.2 million for Q3 2025, which was up 1376.46% from -$5.8 million recorded in Q2 2025.
  • In the past 5 years, MediWound's Cash from Operations registered a high of $750000.0 during Q4 2022, and its lowest value of -$5.8 million during Q2 2025.
  • Moreover, its 5-year median value for Cash from Operations was -$3.6 million (2024), whereas its average is -$3.2 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first skyrocketed by 13355.7% in 2022, then crashed by 80674.85% in 2024.
  • Over the past 5 years, MediWound's Cash from Operations (Quarter) stood at -$2.2 million in 2021, then skyrocketed by 133.56% to $750000.0 in 2022, then tumbled by 448.67% to -$2.6 million in 2023, then soared by 37.4% to -$1.6 million in 2024, then plummeted by 97.86% to -$3.2 million in 2025.
  • Its last three reported values are -$3.2 million in Q3 2025, -$5.8 million for Q2 2025, and -$4.1 million during Q1 2025.